Burney Co. Sells 3,328 Shares of HCA Healthcare, Inc. $HCA

Burney Co. lessened its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 11.7% during the first quarter, Holdings Channel reports. The fund owned 25,006 shares of the company’s stock after selling 3,328 shares during the period. Burney Co.’s holdings in HCA Healthcare were worth $11,834,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently modified their holdings of the stock. Norges Bank bought a new stake in shares of HCA Healthcare during the 4th quarter worth about $1,262,513,000. Life Cycle Investment Partners Ltd bought a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $374,037,000. Viking Global Investors LP increased its stake in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in HCA Healthcare by 4,545.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares during the period. Finally, Danske Bank A S bought a new position in HCA Healthcare during the 3rd quarter worth $115,530,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of several research reports. Wells Fargo & Company decreased their price target on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research note on Monday, April 27th. Barclays dropped their price target on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Leerink Partners lowered their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Oppenheimer reduced their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, Cantor Fitzgerald dropped their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday. Fifteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $500.14.

View Our Latest Report on HCA Healthcare

HCA Healthcare Price Performance

NYSE HCA opened at $417.00 on Tuesday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The business has a fifty day moving average price of $400.65 and a two-hundred day moving average price of $462.33. The stock has a market capitalization of $92.51 billion, a PE ratio of 14.34, a PEG ratio of 1.30 and a beta of 1.12.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period last year, the firm posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were issued a dividend of $0.78 per share. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is 10.73%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.